Park JH, Saposnik G, Ovbiagele B, Markovic D, Towfighi A. Effect of B-vitamins on stroke risk among individuals with vascular disease who are not on antiplatelets: a meta-analysis. Int J Stroke. 2016;11:206 211. doi: 633. Spence JD, Yi Q, Hankey GJ. B vitamins in stroke prevention: time to reconsider. Lancet Neurol. 2017;16:750 760. doi: 10.1016/S1474- CLINICAL STATEMENTS AND GUIDELINES Kleindorfer 634. Tian T, Yang KQ, Cui JG, Zhou LL, Zhou XL. Folic acid supplementation for stroke prevention in patients with cardiovascular disease. Am J Med Sci. 635. Zeng R, Xu CH, Xu YN, Wang YL, Wang M. The effect of folate fortifica- tion on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis. Public Health Nutr. 2015;18:1514 1521. doi: 636. Zhao M, Wu G, Li Y, Wang X, Hou FF, Xu X, Qin X, Cai Y. Meta- analysis of folic acid efficacy trials in stroke prevention: in- sight into effect modifiers. Neurology. 2017;88:1830 1838. doi: 637. Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, Li J, Fu J, Huang X, Cheng X, et al. Homocysteine and stroke risk: modifying effect of methylenetet- rahydrofolate reductase C677T polymorphism and folic acid intervention. 638. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observa- tional studies. BMJ. 2005;330:63. doi: 10.1136/bmj.38302.504063.8F 639. Bashir A, Lipton RB, Ashina S, Ashina M. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 640. Serrano F, Arauz A, Uribe R, Becerra LC, Mantilla K, Zerme o F. Long-term follow-up of patients with migrainous infarction. Clin Neurol Neurosurg. 641. Hoekstra-van Dalen RA, Cillessen JP, Kappelle LJ, van Gijn J. Cerebral infarcts associated with migraine: clinical features, risk factors and follow- up. J Neurol. 1996;243:511 515. doi: 10.1007/BF00886872 642. 